Regen Med. 2010 Mar; 5(2) : 267-78. Stem cell-derived dopamine neurons for brain repair in Parkinson’s disease. Fricker-Gates RA, Gates MA. Keele University, Keele, Staffordshire, UK. r.a.fricker-gates@hfac.keele.ac.uk Abstract One of the prospects for a curative treatment for Parkinson’s disease is to replace the lost dopaminergic neurons. Preclinical and clinical trials have demonstrated that dissected fetal…

IDrugs. 2010 Feb; 13(2) : 82-4. Parkinson’s disease and related disorders–XVIII WFN World Congress. Grosset D. Southern General Hospital, 1345 Govan Road, Glasgow, G51 4TF, UK. d.grosset@clinmed.gla.ac.uk Abstract The XVIII World Federation of Neurology (WFN) World Congress on Parkinson’s Disease and Related Disorders, held in Miami, FL, USA, included topics covering new therapeutic developments in…

Curr Med Chem. 2010; 17(8) : 759-66. Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery. Gunaseeli I, Doss MX, Antzelevitch C, Hescheler J, Sachinidis A. Center of Physiology and Pathophysiology, Institute of Neurophysiology, and Center of Molecular Medicine, University of Cologne (CMMC), Robert-Koch Str. 39, Cologne, Germany. Abstract Human…

J Neurol Sci. 2010 Feb 15; 289(1-2) : 93-103. Epub 2009 Sep 4. Restorative approaches in Parkinson’s Disease: which cell type wins the race? Meyer AK, Maisel M, Hermann A, Stirl K, Storch A. Department of Neurology, Dresden University of Technology, Dresden, Germany. Abstract Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder and is…

J Cell Biochem. 2010 Feb 1; 109(2) : 292-301. Human ES and iPS cells as cell sources for the treatment of Parkinson’s disease: current state and problems. Hwang DY, Kim DS, Kim DW. Stem Cell Research Center, 21C Frontier R&D Program of Ministry of Education, Science and Technology, Yonsei University Medical Center, Seoul, South Korea.…

J Clin Invest. 2010 Jan 4; 120(1): 29-40. doi: 10.1172/JCI40543. Stem cells in human neurodegenerative disorders–time for clinical translation? Lindvall O, Kokaia Z. Laboratory of Neurogenesis and Cell Therapy, Wallenberg Neuroscience Center, University Hospital, Lund, Sweden. olle.lindvall@med.lu.se Abstract Stem cell-based approaches have received much hype as potential treatments for neurodegenerative disorders. Indeed, transplantation of stem…

Brain Res. 2010 Jan 22; 1311 : 12-27. Epub 2009 Nov 26. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson’s disease. Cova L, Armentero MT, Zennaro E, Calzarossa C, Bossolasco P, Busca G, Lambertenghi Deliliers G, Polli E, Nappi G, Silani V, Blandini F. Department…

J Clin Invest. 2010 Jan 4; 120(1): 29-40. d oi: 10.1172/JCI40543. Stem cells in human neurodegenerative disorders–time for clinical translation? Lindvall O, Kokaia Z. Laboratory of Neurogenesis and Cell Therapy, Wallenberg Neuroscience Center, University Hospital, Lund, Sweden. olle.lindvall@med.lu.se Abstract Stem cell-based approaches have received much hype as potential treatments for neurodegenerative disorders. Indeed, transplantation of…

Ginekol Pol. 2009 Dec; 80(12) : 935-41. Physiological and pathological consequences of a presence of germ line stem cells in adult tissues -[Article in Polish] Ratajczak MZ, Machaliński B, Czajka R, Zuba-Surma E, Poziomkowska-Gesicka I, Słowik-Zyłka D. Zakład Fizjologii Katedry Fizjopatologii Pomorskiej Akademii Medycznej, Szczecin. mzrata01@louisville.edu Abstract Various therapheutic strategies employing stem cells have been…

Rinsho Shinkeigaku. 2009 Nov; 49(11) : 890-2. Cell therapy for Parkinson disease – [Article in Japanese] Muramatsu S. Division of Neurology, Jichi Medical University. Abstract Advances in the field of stem cell research have raised hopes of creating novel cell replacement therapies for Parkinson disease (PD), although double-blinded clinical trials have met with controversial success…